Plants Standardized phytosubstance production is the key that unlocks the door to phytopharmaceuticals.

The foundation of plant based medicine.

  • Environmentally Controlled Biosphere

  • Manufacturing & Processing Standardized Phyto-Compounds

IP creation through environmental recipe.

  • Environmentally Modified Organism Enhancement in proprietary plant bioreactor system

  • Chemovar Propagation Research

New phyto-substances with incredible health benefits are being discovered daily, and our production methods are the key to unlock their potential as global medicines. These new discoveries, together with rapid technological advances in novel delivery methods, are at the forefront of a phyto-based healthcare revolution.

With meticulous research, obsessive standardization techniques and a passionate, driven team, we intend to revolutionize the medical industry.

 

“The World Health Organization (WHO) estimates that 80 percent of the world’s population still uses traditional remedies, including plants, as their primary health care tools.”

Standardization Of Production

For plant material to be considered medicine the industry must address the basic pharmaceutical principles:

  • Consistent standardized plant compounds and secondary metabolites within acceptable parameters +/- 10%

  • Pesticide and contaminant free production

Kensana Favicon 144

Full control of plant compound growth and production process to ensure consistency of each active compound within every batch:

  • Expediting drug-to-drug development focusing on creating new medications by leveraging existing compounds as a starting point.

  • Standardizing plant-based medications to allow for clinical trials.

Phyto Production Capabilities

COMPUTER-CONTROLLED ENVIRONMENTAL SYSTEM

Kensana is revolutionizing drug production with our proprietary custom scalable plant bioreactors. These advanced systems ensures efficient, sustainable, and high-yield manufacturing, paving the way for groundbreaking advancements in phytopharmaceutical development.

Organic fertilizers and media, with no pesticides, permit us to deliver products which are natural and safe. A clean, strictly controlled indoor environment eliminates the need for pesticide applications. The final product is free of chemical toxins, to ensure maximum therapeutic benefit.

Our pharma grade, GMP facility will be capable of meeting regulatory standards in any jurisdiction. This proven and innovative technology facilitates the most standardized growth in the industry.

PRECISELY CONTROLLED CULTIVATION

For plants or plant material to be considered medicine the industry must address the basic pharmaceutical principles:

Consistent standardized plant compound profiles within acceptable parameters of +/- 10%, ensuring consistent efficacy batch to batch.

Standardization means the ability to completely control the growth and production process to ensure consistency of each active compound with every batch. No one has done this consistently or economically before. The Kensana team has proven out this model. Kensana is the only group with the collective knowledge to produce a consistent standardized product that meets stringent demands.

Pharma-grade, GMP Facility capable of meeting regulatory standards in any jurisdiction.

Partners With Deep Roots

Martin Bauer Group

  • MBG dates back to 1930 and includes an extraction portfolio of more than 200 different plants from over 80 countries. The selection covers Phyto-pharmaceutical extracts as well as extracts for food supplements.

  • By combining Martin Bauer Group’s Expertise as one of the world’s largest producers of plant based GMP pharmaceutical API’s and food with Kensana’s strengths in proven R&D and standardized production of cannabinoids we plan to create strategic alliances at a global level to achieve our vision.